Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cellavita HD in Huntington's Disease
NCT03252535Phase 2Completed
- Sponsor
- Azidus Laboratories Limited
- Start
- Jan 2018
- Primary completion
- Mar 2021
- Modality
- Stem Cell Therapies
- Countries
- 1
01
Overview
A Phase 2 trial of NestaCell in Huntington's disease (HD), sponsored by Azidus Laboratories Limited. Started Jan 2018; status: completed.
02
Drugs
NestaCell
03
Conditions
Huntington's disease (HD)
Beyond the preview
Go deeper on NCT03252535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03252535.